More than 2,000 Britons are diagnosed with laryngeal cancer every year in the ... 55 per cent will live for 10 years or more.
Chimeric antigen receptor T-cell or CAR T therapy shows promise for patients with refractory or relapsing B-cell lymphomas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback